Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target

NCT01618513 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
84
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Aarhus

Collaborators